Testosterone pellets are small, rice-grain-sized cylinders of crystalline testosterone that a clinician implants under the skin, typically in the hip or buttock area, where they dissolve slowly and release hormone into the bloodstream over several months. The FDA first approved fused crystalline testosterone pellets in the United States in 1972, though they were not commercially marketed until 2008 under the brand name Testopel.1PubMed Central. A Review of Testosterone Pellets in the Treatment of Hypogonadism They are one of several options for testosterone replacement therapy, alongside injections, gels, patches, and nasal formulations, and they occupy a particular niche for men who want steady hormone levels without the hassle of daily or weekly dosing.
How the Implantation Works
The procedure is done in a clinic and usually takes about ten minutes. After numbing a small patch of skin with local anesthetic, a clinician makes a tiny incision and uses a trocar, a hollow needle-like instrument, to slide the pellets into the fatty tissue just beneath the skin. Most men receive between two and six pellets at a time, with a typical total dose ranging from about 150 to 450 mg depending on individual needs.2PubMed Central. Testosterone and Cardiovascular Health: Physiology, Pharmacokinetics and Clinical Implications – Section: 4.3 Pellets Formulation The incision is small enough to close with adhesive strips rather than stitches. Aftercare is minimal: keep the site clean and dry for a few days, and avoid vigorous lower-body exercise for roughly a week so the pellets stay in place while the tissue heals around them. Some clinical guidelines note doses as high as four to six 200-mg pellets implanted every four to six months.3The Journal of Clinical Endocrinology & Metabolism. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
How Pellets Release Testosterone
The pharmacokinetics of pellets are one of their main selling points. After implantation, there is a brief initial burst where testosterone spikes, peaking around half a day after the procedure. In a study of 14 hypogonadal men, this peak averaged about 49 nmol/L. That spike settles quickly into a stable plateau: by day two, levels were around 35 nmol/L, and they stayed essentially flat through day 63.4PubMed. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men This steady-state release is what distinguishes pellets from intramuscular injections, which tend to create peaks and troughs as the dose wears off between shots.
The absorption follows a predictable, nearly linear pattern. The half-duration of a 200-mg pellet is roughly two and a half months, with each pellet releasing about 1.5 mg of testosterone per day.5The Journal of Clinical Endocrinology & Metabolism. Pharmacokinetics and Pharmacodynamics of Testosterone Pellets in Man The elimination half-life works out to about 70 to 75 days, and therapeutic levels generally persist for four to six months depending on the total dose used.6PubMed Central. Testosterone and Cardiovascular Health: Physiology, Pharmacokinetics and Clinical Implications – Section: 4.3 Pellets Formulation By around day 189, nearly all of the testosterone has been absorbed, so nothing needs to be surgically removed.7PubMed. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men
What Symptoms Improve and How Quickly
The main reason men choose pellets is to relieve the symptoms of low testosterone: low libido, erectile difficulty, fatigue, depressed mood, and a general sense of diminished vitality. A study tracking men who received 900-mg subcutaneous pellet implants found statistically significant improvement in erectile function, sexual desire, intercourse satisfaction, and overall satisfaction scores on a standard sexual function questionnaire. Scores on a broader androgen-deficiency questionnaire also improved at every follow-up visit, reaching statistical significance at day 85.8The Journal of Sexual Medicine. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated with Androgen Deficiency – Section: Results
Depression symptoms showed a trend toward improvement in that same study, with scores on a depression scale dipping most around day 85, but the changes did not reach statistical significance.9The Journal of Sexual Medicine. Pharmacokinetics, Clinical Efficacy, Safety Profile, and Patient-Reported Outcomes in Patients Receiving Subcutaneous Testosterone Pellets 900 mg for Treatment of Symptoms Associated with Androgen Deficiency – Section: Results That is consistent with the broader testosterone replacement literature: sexual symptoms tend to respond more reliably and quickly than mood symptoms, which are influenced by many factors beyond hormone levels alone.
Side Effects and Complications
Pellets have a relatively modest side-effect profile, but there is one complication that is essentially unique to this delivery method: extrusion. Sometimes the body pushes a pellet back out through the skin before it fully dissolves. This happens after roughly 10 to 12 percent of implantation procedures.10European Journal of Endocrinology. A randomised controlled clinical trial of antibiotic impregnation of testosterone pellet implants to reduce extrusion rate It is more annoying than dangerous, but it means you lose some of the dose and may need an earlier reimplantation. A controlled study tested whether washing pellets in antiseptic before insertion would cut the extrusion rate, and it did not help: the washed group had a 12 percent extrusion rate compared to 11 percent in the control group.11PubMed. Extrusion of testosterone pellets: a randomized controlled clinical study – Section: RESULTS Nor did the operator or the batch of pellets make a difference. Infection requiring antibiotics occurred after about 4 percent of procedures in that study, and notably, 60 percent of men who got an infection went on to extrude a pellet, suggesting that local infection destabilizes the implant site.12PubMed. Extrusion of testosterone pellets: a randomized controlled clinical study – Section: RESULTS
Other potential side effects are shared across all testosterone replacement methods. Erythrocytosis, an increase in red blood cell count, is one that clinicians monitor with blood work. The steady pharmacokinetics of pellets may cause less erythrocytosis than shorter-acting injectable testosterone esters, which produce higher peak levels.13PubMed. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets All forms of testosterone replacement also raise estradiol levels to some degree. With pellets, estradiol increases tend to be temporary, lasting up to about six months before normalizing, whereas injections and gels can keep estradiol elevated for longer.14Sexual Medicine. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate‐Specific Antigen – Section: Discussion Gynecomastia from elevated estradiol is uncommon, affecting roughly 2 percent of men on testosterone therapy, and is usually reversible.
Prostate Safety
One of the most common fears around testosterone replacement is whether it feeds prostate cancer. The evidence from long-term pellet studies is reassuring, though not a blanket guarantee. In a large safety dataset spanning nearly 3,000 man-years of testosterone pellet treatment, prostate cancer was diagnosed at a rate of about one case per 212 treatment-years. All tumors detected were clinically localized and suitable for curative treatment. Starting testosterone therapy did not significantly change PSA levels, and any initial PSA fluctuation did not predict who would later be diagnosed with cancer.15The Journal of Sexual Medicine. Is Testosterone Treatment Good for the Prostate? Study of Safety During Long-Term Treatment
A separate study that directly compared gels, injections, and pellets found no significant PSA increases in any formulation group. Among men in the pellet group, only one was diagnosed with prostate cancer over the study period, and there were no cancer recurrences in subjects who had a prior history of prostate cancer.16Sexual Medicine. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate‐Specific Antigen – Section: Results None of this means prostate monitoring is optional. Standard practice still includes regular PSA checks and digital rectal exams, especially in the first year of therapy and for men over 40. But the old idea that testosterone therapy inevitably stokes prostate cancer has not held up to scrutiny in these longer-term data sets.
Pellets Versus Injections and Gels
When men are choosing between the main testosterone replacement options, the decision usually comes down to convenience, cost, and how well they tolerate the mechanics of each method. A cross-sectional survey of men on testosterone therapy found that overall satisfaction rates were remarkably similar across delivery methods: about 68 percent for gels, 73 percent for injections, and 70 percent for pellets.17PubMed Central. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices – Section: Results So no single format clearly dominates in terms of how happy men are with it.
What does differ is why men prefer each one. Pellet users rated ease of use as their top reason, with about 64 percent citing it, significantly higher than injection or gel users. Convenience was also a standout factor for pellets, chosen by roughly 58 percent of pellet users compared to about 26 percent of injection users and 19 percent of gel users.18PubMed Central. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices – Section: Results This makes intuitive sense: once pellets are in, you do not think about them for months. There is no daily gel application, no worrying about skin-to-skin transfer to a partner or child, and no weekly injections to schedule. Gel users, by contrast, most often chose that method because their doctor recommended it. Injection users cited lower cost as a deciding factor more than the other groups.
The Cost Question
Cost is the elephant in the room for pellet therapy. Because implantation requires an in-office procedure every few months, the out-of-pocket expense tends to be higher than self-administered injections or generic topical gels. Insurance coverage varies widely. A survey of men who had started on pellets found that convenience was the primary motivator for choosing them, with about 69 percent naming it as the most important factor. But among the roughly 28 percent who later discontinued pellet therapy, cost was the number-one reason, cited by half of those who stopped.19The Journal of Sexual Medicine. Factors Influencing Patient Decisions to Initiate and Discontinue Subcutaneous Testosterone Pellets (Testopel) for Treatment of Hypogonadism Testosterone levels were the same between men who stayed on pellets and those who switched away, so effectiveness was not the issue. The barrier was purely financial.
If you are considering pellets, it is worth calling your insurance provider before the first procedure. Some plans cover the pellets themselves but not the implantation fee, or vice versa. Compounded pellets, made by specialty pharmacies rather than the brand-name manufacturer, are sometimes cheaper, though their regulation is different from FDA-approved products.
Branded Versus Compounded Pellets
Testopel is the only FDA-approved testosterone pellet in the United States. Compounded pellets are made by pharmacies under state regulation rather than through the full FDA approval process, and they vary in price and formulation. A randomized trial comparing Testopel to a compounded pellet (designated E100) found that testosterone levels were not statistically different between the two at two, four, or six months. Safety markers including PSA, hemoglobin, and hematocrit were also comparable. The one difference that emerged was a transient divergence in estradiol levels at two months, with the compounded pellet group running higher, but this equalized by four months.20Sexual Medicine. Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial – Section: Results
This is a single trial, so it does not settle the debate entirely. The concern with compounded products is quality consistency from batch to batch and pharmacy to pharmacy, since they are not subject to the same manufacturing standards as FDA-approved drugs. If you go the compounded route, choosing a pharmacy that follows United States Pharmacopeia (USP) compounding standards and has independent assay verification is a reasonable precaution.
Effects on Fertility
This is a critical point that many men do not realize until it is too late: testosterone pellets, like all exogenous testosterone, suppress the hormonal signals that drive sperm production. When you add testosterone from outside the body, the brain’s pituitary gland dials back its own signaling hormones, which in turn causes the testes to produce less testosterone locally and fewer sperm. Data from clinical trials show that intratesticular hormone markers drop significantly in men using pellets, confirming this suppressive effect.21PubMed Central. Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials – Section: Results
For men who might want to father children in the future, this makes pellets a poor first choice, at least in isolation. Unlike gels or injections, which clear the body within days to weeks after stopping, pellets cannot be removed once implanted (short of a surgical procedure to dig them out). That means if you change your mind about fertility partway through a pellet cycle, you are committed to several more months of suppression before the hormone clears and your natural production has a chance to recover. Some clinicians prescribe additional medications alongside pellet therapy to help preserve fertility, but these are off-label approaches. If future fertility matters to you, discuss it explicitly with your doctor before your first implantation, not after.
Bone Density and Longer-Term Skeletal Health
Low testosterone is a well-established risk factor for bone loss in men, and this is one area where pellet therapy shows a clear benefit. A long-term study of hypogonadal men regularly treated with subcutaneous testosterone pellets found that their bone mineral density was not different from the age-matched reference range for men with normal testosterone levels.22PubMed. Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism In other words, pellet therapy maintained bone mass at the level you would expect in a healthy man, preventing the osteopenia and osteoporosis that can develop with prolonged testosterone deficiency.
Case reports have gone further, documenting men who reversed an existing osteoporosis diagnosis after starting pellet therapy, confirmed by repeat bone density scanning within a year.23PubMed. Subcutaneous testosterone pellet therapy for reversal of male osteoporosis: a review and case report Case reports are not the same weight of evidence as controlled trials, but the direction is consistent with what the broader literature shows about testosterone and bone health. For men with both low testosterone and low bone density, pellets address both problems simultaneously, and the steady delivery may matter here too, since bone metabolism responds to consistent hormone exposure rather than the peaks and troughs of some other formulations.
What Happens When You Stop
Because pellets dissolve completely over several months, “stopping” pellet therapy mostly means not getting your next implantation. Your testosterone levels will gradually decline as the current pellets are absorbed, and symptoms may return as levels drop below the therapeutic range. This taper is gentler than abruptly stopping injections, but it is not instantaneous: expect a slow slide back toward your baseline over several weeks to months depending on how much of the current dose remains.
Recovery of your body’s own testosterone production after long-term replacement therapy of any kind is unpredictable. Some men bounce back relatively quickly; others experience prolonged suppression, especially after years of therapy. The pituitary-testicular axis takes time to “wake up” after being suppressed. If you are discontinuing testosterone replacement, your clinician may monitor your hormone levels periodically and, in some cases, use medications to help restart natural production. The key thing to know is that stopping pellets is not as simple as just deciding not to go back for your next appointment. Plan the transition with your provider, especially if you are stopping for fertility reasons, since the timeline for sperm recovery can stretch to many months.
Who Is and Is Not a Good Candidate
Pellets make the most sense for men who have a confirmed diagnosis of testosterone deficiency, prefer a low-maintenance approach, are not planning to conceive in the near future, and can manage the upfront cost. They are a poor fit for men who need fine-grained dose adjustments, since once the pellets are in, you cannot easily change the dose until the next cycle. They are also less ideal for men with a history of keloid scarring or skin conditions at the implantation site, since repeated minor incisions every few months could be problematic.
Men with untreated sleep apnea, severe polycythemia, or certain hormone-sensitive cancers are generally not candidates for any form of testosterone replacement, pellets included. The Endocrine Society’s clinical practice guidelines emphasize that testosterone therapy should only be initiated in men with clearly documented deficiency confirmed by at least two morning blood draws, along with symptoms consistent with low testosterone.24The Journal of Clinical Endocrinology & Metabolism. Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline Pellets are a delivery vehicle, not a shortcut around proper diagnosis.
Monitoring While on Pellet Therapy
Even though pellets are “set it and forget it” in terms of daily dosing, they are not set-and-forget in terms of medical follow-up. Responsible pellet therapy includes blood work before and during treatment. Your clinician will typically check total testosterone levels, hematocrit to watch for erythrocytosis, PSA for prostate screening, and liver function markers. Most guidelines recommend checking these at baseline, a few weeks after the first implantation, and periodically thereafter.
Timing of blood draws matters. Because pellets produce their highest levels in the first month and taper gradually, a blood draw at two months will look different from one at five months. A comparison trial of branded and compounded pellets illustrated this clearly: median testosterone at two months was in the 540 to 700 ng/dL range, dropping to roughly 270 to 290 ng/dL by four months and around 210 to 240 ng/dL at six months.25Sexual Medicine. Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial – Section: Results Understanding this natural taper helps you and your doctor interpret your numbers correctly and decide the optimal timing for reimplantation rather than reflexively increasing the dose because a late-cycle blood draw came back low.